Estimates based on drug properties and standard treatment parameters.
43.2 mL/min
Moderately Dialyzable
Some removal expected. Half-life: 9 minutes. Monitor drug levels. Short half-life suggests rapid endogenous clearance may minimize impact of HD.
Data Used:
✅
protein_binding, molar_mass, mw_factor, vd, vd_factor, half_life
Free fraction:
0.4
Mw factor:
1
Vd factor:
0.5
Hl factor:
0.8
Half life:
9 minutes
Half life category:
Ultra-short (< 1h)
2.8 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 9 minutes.
Data Used:
✅
protein_binding, molar_mass, half_life
Free fraction:
0.4
Half life:
9 minutes
Half life category:
Ultra-short (< 1h)
Low Risk
This drug is unlikely to be significantly removed by TPE.
Data Used:
✅
protein_binding, vd, half_life
Half life:
9 minutes
Half life category:
Ultra-short (< 1h)
Low Effectiveness
Poor candidate for hemoperfusion. Drug is distributed in tissues.
Data Used:
✅
vd, half_life
Half life:
9 minutes
Half life category:
Ultra-short (< 1h)
